Evidence map›Paper›PMID 41304356›Full record

ReviewPolymers2025

Machine Learning-Driven Paradigm for Polymer Aging Lifetime Prediction: Integrating Multi-Mechanism Coupling and Cross-Scale Modeling.

Bing Zeng, Shuo Wu, Shufang Yao

Abstract readReview
In one paragraph

Review in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bing ZengCABR Testing Center Company Limited, China Academy of Building Research, Beijing 100013, China.ORCID 0009-0004-0992-9462
Shuo WuCABR Testing Center Company Limited, China Academy of Building Research, Beijing 100013, China.
Shufang YaoCABR Testing Center Company Limited, China Academy of Building Research, Beijing 100013, China.ORCID 0009-0006-6498-4362

Funding

the National Key R&D Program of China 2022YFC3801600
6 · The paper itself

Abstract

This review systematically examined the transformative role of machine learning in predicting polymer aging lifetime, addressing critical limitations of conventional methods such as the Arrhenius model, time-temperature superposition principle, and numerical fitting approaches. The primary objective was to establish a comprehensive framework that integrates multi-mechanism coupling with dynamic data-driven modeling to enhance prediction accuracy across complex aging scenarios. Four key machine learning categories demonstrate distinct advantages: support vector machines effectively capture nonlinear interactions in multi-stress environments; neural networks enable cross-scale modeling from molecular dynamics to macroscopic failure; decision tree models provide interpretable feature importance quantification; and hybrid approaches synergistically combine complementary strengths. These methodologies have shown significant success in critical industrial applications, including building trades, photovoltaic systems, and aerospace composites, creating an integrated predictive system that bridges molecular-level dynamics with service-life performance. By transforming life prediction from empirical extrapolation to mechanism-based simulation, this machine-learning-driven paradigm offers robust methodological support for engineering safety design in diverse polymer applications through its capacity to model complex environmental interactions, adapt to real-time monitoring data, and elucidate underlying degradation mechanisms.

Indexed as

aging life predictiondecision tree modelneural network modelpolymersupport vector machine

Identifiers

PMID41304356
PMCPMC12656554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.